Berkshire Hathaway

• 8-KPositiveEarnings

  Filed Aug 11

  Investment gains and the prior-year Kraft Heinz impairment drove the GAAP earnings surge; BNSF and energy lifted operating earnings.

• 10-QQ2 FY2026Positive

  Filed Aug 10

  Investment gains drove the GAAP earnings jump; OxyChem and BNSF lifted operating profit while GEICO claims costs rose.

  • Revenue$101.8BYoY +10.0%
  • Net income$25.7BYoY +107.5%

• 8-KPositiveEarningsCEO/CFO change

  Filed May 7

  Narrower investment losses and a swing to FX gains lift earnings; Charles C. Chang will succeed Marc D. Hamburg as CFO.

• 10-QQ1 FY2026PositiveLegal / investigation

  Filed May 4

  Smaller investment losses drove the earnings surge, while rising claims and policy-acquisition costs cut GEICO underwriting profit.

  • Revenue$93.7BYoY +4.4%
  • Net income$10.1BYoY +119.6%

• 8-KDebt financing

  Filed Apr 16

  Issued six tranches of yen-denominated senior notes through Mizuho Securities USA and Merrill Lynch International.

• 8-K

  Filed Mar 5

  Share repurchases began during Berkshire’s leadership transition under its policy of buying shares deemed below conservatively determined intrinsic value.

• 8-KNegativeEarningsImpairment / charge

  Filed Mar 2

  Kraft Heinz and Occidental investment impairments weighed on GAAP earnings; operating earnings also fell.

• 10-KFY2025MixedImpairment / charge

  Filed Mar 2

  Lower investment gains and Kraft Heinz/Occidental impairments drove the GAAP profit drop; Abel takes charge of capital allocation as OxyChem closes.

  • Revenue$371.4BYoY 0.0%
  • Net income$67.0BYoY −24.8%

Coverage: 10-K and 8-K filings filed since Mar 2, 2026; 10-Q since May 4, 2026.

Company data: Wikidata Q217583